Mitral Stenosis III: Medical Management

Antibiotic prophylaxis prevents bacterial infections, particularly streptococcal pharyngitis, which can lead to rheumatic fever and further valve damage. Long-term prophylaxis regimens include intramuscular Penicillin G every four weeks, oral Penicillin V twice daily, Sulfadiazine daily, or Erythromycin twice daily. These medications are essential for secondary prevention in patients with established rheumatic heart disease.

Anticoagulants like warfarin or direct oral anticoagulants (DOACs) are prescribed for patients with severe left atrial dilation to reduce the risk of atrial thrombus formation. Anticoagulation therapy remains essential in patients with atrial fibrillation to prevent thromboembolism. These medications work alongside rate-control agents to manage complications associated with mitral stenosis.

Atrial fibrillation is initially managed with cardioversion to restore normal sinus rhythm. If cardioversion fails, rate control is achieved using beta-blockers, digoxin, or calcium channel blockers. Anticoagulation therapy remains essential to prevent thromboembolism in these patients with atrial fibrillation complications.

Patients with severe mitral stenosis should avoid strenuous activities, competitive sports, and pregnancy, as these increase heart rate and cardiac workload, potentially causing acute decompensation. Low-impact exercises like walking or swimming under medical supervision are recommended alternatives to maintain fitness while protecting cardiac function.

Surgical interventions include valvuloplasty, which separates fused mitral valve leaflets to improve blood flow; percutaneous transluminal valvuloplasty, a minimally invasive balloon catheter procedure; and valve replacement with a prosthetic valve when valvuloplasty is not feasible. These procedures restore normal blood flow and reduce symptoms when medical management is insufficient.

Surgical intervention is considered when medical management and lifestyle adjustments are insufficient to control symptoms and prevent complications. The choice between valvuloplasty and valve replacement depends on valve anatomy and disease severity. Understanding clinical features and diagnostic tests helps determine the appropriate timing and type of surgical intervention needed.

Effective mitral stenosis management combines preventive strategies, judicious medication use, lifestyle modifications, and appropriate surgical interventions. This integrated approach reduces symptoms, prevents complications like thromboembolism and cardiac decompensation, and improves patient quality of life. Regular monitoring and adherence to preventive regimens are essential for long-term success.